Price | 4.93 | EPS | 0 | |
Shares | 18 | P/E | 131 | |
MCap | 88 | P/FCF | 64 | |
Net Debt | 4 | EBIT | 1 | |
TEV | 91 | TEV/EBIT | 95 | TTM 2019-09-30, in MM, except price, ratios |
10-Q | 2020-09-30 | Filed 2020-11-13 |
10-Q | 2020-06-30 | Filed 2020-08-11 |
10-Q | 2020-03-31 | Filed 2020-05-11 |
10-K | 2019-12-31 | Filed 2020-03-18 |
10-Q | 2019-09-30 | Filed 2019-11-12 |
10-Q | 2019-06-30 | Filed 2019-08-14 |
10-Q | 2019-03-31 | Filed 2019-05-13 |
10-K | 2018-12-31 | Filed 2019-03-15 |
10-Q | 2018-09-30 | Filed 2018-11-13 |
10-Q | 2018-06-30 | Filed 2018-08-13 |
10-Q | 2018-03-31 | Filed 2018-05-15 |
10-K | 2017-12-31 | Filed 2018-03-29 |
10-Q | 2017-09-30 | Filed 2017-11-13 |
10-Q | 2017-06-30 | Filed 2017-08-11 |
10-Q | 2017-03-31 | Filed 2017-05-15 |
10-K | 2016-12-31 | Filed 2017-03-28 |
10-Q | 2016-09-30 | Filed 2016-11-14 |
10-Q | 2016-06-30 | Filed 2016-08-15 |
10-Q | 2016-03-31 | Filed 2016-05-13 |
10-K | 2015-12-31 | Filed 2016-03-31 |
10-Q | 2015-09-30 | Filed 2016-03-29 |
10-Q | 2015-06-30 | Filed 2016-03-29 |
10-Q | 2015-03-31 | Filed 2016-03-29 |
10-K | 2014-12-31 | Filed 2015-03-23 |
10-Q | 2014-09-30 | Filed 2014-11-14 |
10-Q | 2014-06-30 | Filed 2014-08-14 |
10-Q | 2014-03-31 | Filed 2014-05-15 |
10-K | 2013-12-31 | Filed 2014-03-31 |
10-Q | 2013-09-30 | Filed 2013-11-13 |
10-Q | 2013-06-30 | Filed 2013-08-14 |
10-Q | 2013-03-31 | Filed 2013-05-10 |
10-K | 2012-12-31 | Filed 2013-03-19 |
10-Q | 2012-06-30 | Filed 2012-08-08 |
10-Q | 2012-03-31 | Filed 2012-05-15 |
10-K | 2011-12-31 | Filed 2012-03-29 |
10-Q | 2011-09-30 | Filed 2011-11-10 |
10-Q | 2011-06-30 | Filed 2011-08-05 |
10-Q | 2011-03-31 | Filed 2011-05-06 |
10-K | 2010-12-31 | Filed 2011-03-07 |
10-Q | 2010-09-30 | Filed 2010-11-09 |
10-Q | 2010-06-30 | Filed 2010-08-16 |
10-Q | 2010-03-31 | Filed 2010-05-17 |
10-K | 2009-12-31 | Filed 2010-03-08 |
8-K | 2020-11-10 | |
8-K | 2020-10-29 | |
8-K | 2020-08-06 | |
8-K | 2020-06-01 | |
8-K | 2020-05-16 | |
8-K | 2020-05-07 | |
8-K | 2020-05-05 | |
8-K | 2020-04-09 | |
8-K | 2020-03-12 | |
8-K | 2020-01-28 | |
8-K | 2019-11-04 | |
8-K | 2019-08-08 | |
8-K | 2019-08-05 | |
8-K | 2019-05-29 | |
8-K | 2019-05-09 | |
8-K | 2019-03-07 | |
8-K | 2019-02-06 | |
8-K | 2019-01-02 | |
8-K | 2018-12-19 | |
8-K | 2018-11-08 | |
8-K | 2018-11-01 | |
8-K | 2018-10-25 | |
8-K | 2018-08-09 | |
8-K | 2018-05-30 | |
8-K | 2018-05-10 | |
8-K | 2018-03-06 | |
8-K | 2018-02-21 | |
8-K | 2018-02-14 | |
8-K | 2018-02-06 | |
8-K | 2018-01-31 | |
8-K | 2017-12-28 |
Part I: Financial Information |
Item 1. Financial Statements |
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations |
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
Item 4. Controls and Procedures |
Part Ii: Other Information |
Item 1. Legal Proceedings |
Item 1A. Risk Factors |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
Item 6. Exhibits |
EX-31.1 | inve-ex311_8.htm |
EX-31.2 | inve-ex312_6.htm |
EX-32 | inve-ex32_7.htm |
Balance Sheet | Income Statement | Cash Flow |
---|---|---|
Assets, Equity
|
Rev, G Profit, Net Income
|
Ops, Inv, Fin
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2020
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ______ to ______
Commission File Number: 000-29440
IDENTIV, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE | 77-0444317 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
|
2201 Walnut Avenue, Suite 100 Fremont, California | 94538 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (949) 250-8888
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of exchange on which registered |
|
Common Stock, $0.001 par value per share |
| INVE |
| The Nasdaq Stock Market LLC |
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ |
| Accelerated filer | ☐ |
Non-accelerated filer | ☑ |
| Smaller reporting company | ☑ |
Emerging growth company | ☐ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of November 10, 2020, the registrant had 18,020,175 shares of common stock outstanding.
|
|
| Page |
| |||
Item 1. |
| 3 | |
|
| Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 | 3 |
|
| 4 | |
|
| 5 | |
|
| 7 | |
|
| Notes to Unaudited Condensed Consolidated Financial Statements | 8 |
Item 2. |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations | 28 |
Item 3. |
| 37 | |
Item 4. |
| 37 | |
|
| ||
| |||
Item 1. |
| 38 | |
Item 1A. |
| 39 | |
Item 2. |
| 39 | |
Item 6. |
| 40 | |
|
|
|
|
41 |
2
IDENTIV, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands, except par value)
|
| September 30, |
|
| December 31, |
| ||
|
| 2020 |
|
| 2019 |
| ||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
| $ | 12,294 |
|
| $ | 9,383 |
|
Accounts receivable, net of allowances of $361 and $299 as of September 30, 2020 and December 31, 2019, respectively |
|
| 20,389 |
|
|
| 18,363 |
|
Inventories |
|
| 20,399 |
|
|
| 16,145 |
|
Prepaid expenses and other current assets |
|
| 3,236 |
|
|
| 2,292 |
|
Total current assets |
|
| 56,318 |
|
|
| 46,183 |
|
Property and equipment, net |
|
| 2,392 |
|
|
| 2,042 |
|
Operating lease right-of-use assets |
|
| 3,463 |
|
|
| 4,629 |
|
Intangible assets, net |
|
| 8,138 |
|
|
| 10,104 |
|
Goodwill |
|
| 10,204 |
|
|
| 10,238 |
|
Other assets |
|
| 1,053 |
|
|
| 1,122 |
|
Total assets |
| $ | 81,568 |
|
| $ | 74,318 |
|
LIABILITIES AND STOCKHOLDERS´ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
| $ | 9,460 |
|
| $ | 8,799 |
|
Current portion - contractual payment obligation |
|
| 950 |
|
|
| 1,311 |
|
Current portion - financial liabilities, net of debt issuance costs of $235 and $41 as of September 30, 2020 and December 31, 2019, respectively |
|
| 23,758 |
|
|
| 14,189 |
|
Operating lease liabilities |
|
| 1,957 |
|
|
| 1,814 |
|
Deferred revenue |
|
| 2,180 |
|
|
| 2,193 |
|
Accrued compensation and related benefits |
|
| 2,845 |
|
|
| 1,671 |
|
Other accrued expenses and liabilities |
|
| 2,757 |
|
|
| 4,498 |
|
Total current liabilities |
|
| 43,907 |
|
|
| 34,475 |
|
Long-term contractual payment obligation |
|
| 246 |
|
|
| 360 |
|
Long-term operating lease liabilities |
|
| 2,673 |
|
|
| 3,013 |
|
Long-term deferred revenue |
|
| 495 |
|
|
| 640 |
|
Other long-term liabilities |
|
| 381 |
|
|
| 364 |
|
Total liabilities |
|
| 47,702 |
|
|
| 38,852 |
|
Commitments and contingencies (see Note 17) |
|
|
|
|
|
|
|
|
Stockholders´ equity: |
|
|
|
|
|
|
|
|
Series B convertible preferred stock, $0.001 par value: 5,000 shares authorized; 5,000 shares issued and outstanding as of September 30, 2020 and December 31, 2019 |
|
| 5 |
|
|
| 5 |
|
Common stock, $0.001 par value: 50,000 shares authorized; 19,320 and 18,209 shares issued and 17,966 and 16,986 shares outstanding as of September 30, 2020 and December 31, 2019, respectively |
|
| 19 |
|
|
| 18 |
|
Additional paid-in capital |
|
| 451,271 |
|
|
| 447,965 |
|
Treasury stock, 1,354 and 1,223 shares as of September 30, 2020 and December 31, 2019, respectively |
|
| (9,647 | ) |
|
| (9,043 | ) |
Accumulated deficit |
|
| (409,911 | ) |
|
| (405,504 | ) |
Accumulated other comprehensive income |
|
| 2,129 |
|
|
| 2,025 |
|
Total stockholders´ equity |
|
| 33,866 |
|
|
| 35,466 |
|
Total liabilities and stockholders' equity |
| $ | 81,568 |
|
| $ | 74,318 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
IDENTIV, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, in thousands, except per share data)
|
| Three Months Ended September 30, |
|
| Nine Months Ended September 30, |
| ||||||||||
|
| 2020 |
|
| 2019 |
|
| 2020 |
|
| 2019 |
| ||||
Net revenue |
| $ | 24,859 |
|
| $ | 23,026 |
|
| $ | 62,084 |
|
| $ | 64,785 |
|
Cost of revenue |
|
| 14,974 |
|
|
| 12,500 |
|
|
| 36,987 |
|
|
| 35,672 |
|
Gross profit |
|
| 9,885 |
|
|
| 10,526 |
|
|
| 25,097 |
|
|
| 29,113 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
| 2,380 |
|
|
| 2,125 |
|
|
| 7,398 |
|
|
| 6,229 |
|
Selling and marketing |
|
| 4,245 |
|
|
| 4,470 |
|
|
| 12,978 |
|
|
| 13,689 |
|
General and administrative |
|
| 2,118 |
|
|
| 2,591 |
|
|
| 6,460 |
|
|
| 7,492 |
|
Increase (decrease) in fair value of earnout liability |
|
| — |
|
|
| 175 |
|
|
| (261 | ) |
|
| 175 |
|
Restructuring and severance |
|
| 163 |
|
|
| (87 | ) |
|
| 1,645 |
|
|
| (101 | ) |
Total operating expenses |
|
| 8,906 |
|
|
| 9,274 |
|
|
| 28,220 |
|
|
| 27,484 |
|
Income (loss) from operations |
|
| 979 |
|
|
| 1,252 |
|
|
| (3,123 | ) |
|
| 1,629 |
|
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
| (407 | ) |
|
| (246 | ) |
|
| (1,066 | ) |
|
| (766 | ) |
Foreign currency (losses) gains, net |
|
| (175 | ) |
|
| 168 |
|
|
| (119 | ) |
|
| 96 |
|
Income (loss) before income tax provision |
|
| 397 |
|
|
| 1,174 |
|
|
| (4,308 | ) |
|
| 959 |
|
Income tax provision |
|
| (8 | ) |
|
| (105 | ) |
|
| (99 | ) |
|
| (289 | ) |
Net income (loss) |
| $ | 389 |
|
| $ | 1,069 |
|
| $ | (4,407 | ) |
| $ | 670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
| 369 |
|
|
| (369 | ) |
|
| 104 |
|
|
| (302 | ) |
Liquidation of subsidiary with noncontrolling interest |
|
| — |
|
|
| (33 | ) |
|
| — |
|
|
| (33 | ) |
Comprehensive income (loss) |
| $ | 758 |
|
| $ | 667 |
|
| $ | (4,303 | ) |
| $ | 335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
| $ | 0.01 |
|
| $ | 0.05 |
|
| $ | (0.29 | ) |
| $ | (0.01 | ) |
Diluted |
| $ | 0.01 |
|
| $ | 0.05 |
|
| $ | (0.29 | ) |
| $ | (0.01 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
| 18,144 |
|
|
| 17,006 |
|
|
| 17,868 |
|
|
| 16,933 |
|
Diluted |
|
| 18,650 |
|
|
| 17,766 |
|
|
| 17,868 |
|
|
| 16,933 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
IDENTIV, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in thousands)
|
| Three Months Ended September 30, 2020 |
| |||||||||||||||||||||||||||||||||
|
| Series B Convertible Preferred Stock |
|
| Common Stock |
|
| Additional Paid-in |
|
| Treasury |
|
| Accumulated |
|
| Accumulated Other Comprehensive |
|
| Total Stockholders' |
| |||||||||||||||
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Capital |
|
| Stock |
|
| Deficit |
|
| Income |
|
| Equity |
| |||||||||
Balances, June 30, 2020 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 17,860 |
|
| $ | 19 |
|
| $ | 450,480 |
|
| $ | (9,451 | ) |
| $ | (410,300 | ) |
| $ | 1,760 |
|
| $ | 32,513 |
|
Net income |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 389 |
|
|
| — |
|
|
| 389 |
|
Unrealized income from foreign currency translation adjustments |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 369 |
|
|
| 369 |
|
Issuance of common stock in connection with vesting of stock awards |
|
| — |
|
|
| — |
|
|
| 143 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
Stock-based compensation |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 791 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 791 |
|
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units |
|
| — |
|
|
| — |
|
|
| (37 | ) |
|
| — |
|
|
| — |
|
|
| (196 | ) |
|
| — |
|
|
| — |
|
|
| (196 | ) |
Balances, September 30, 2020 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 17,966 |
|
| $ | 19 |
|
| $ | 451,271 |
|
| $ | (9,647 | ) |
| $ | (409,911 | ) |
| $ | 2,129 |
|
| $ | 33,866 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nine Months Ended September 30, 2020 |
| |||||||||||||||||||||||||||||||||
|
| Series B Convertible Preferred Stock |
|
| Common Stock |
|
| Additional Paid-in |
|
| Treasury |
|
| Accumulated |
|
| Accumulated Other Comprehensive |
|
| Total Stockholders' |
| |||||||||||||||
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Capital |
|
| Stock |
|
| Deficit |
|
| Income |
|
| Equity |
| |||||||||
Balances, December 31, 2019 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 16,986 |
|
| $ | 18 |
|
| $ | 447,965 |
|
| $ | (9,043 | ) |
| $ | (405,504 | ) |
| $ | 2,025 |
|
| $ | 35,466 |
|
Net loss |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| (4,407 | ) |
|
| — |
|
|
| (4,407 | ) |
Unrealized income from foreign currency translation adjustments |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 104 |
|
|
| 104 |
|
Issuance of common stock in connection with vesting of stock awards |
|
| — |
|
|
| — |
|
|
| 505 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
Stock-based compensation |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 2,182 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 2,182 |
|
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units |
|
| — |
|
|
| — |
|
|
| (131 | ) |
|
| — |
|
|
| — |
|
|
| (604 | ) |
|
| — |
|
|
| — |
|
|
| (604 | ) |
Issuance of common stock in connection with Viscount Earnout |
|
| — |
|
|
| — |
|
|
| 157 |
|
|
| — |
|
|
| 489 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 489 |
|
Issuance of shares to non-employees |
|
| — |
|
|
| — |
|
|
| 62 |
|
|
| — |
|
|
| 304 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 304 |
|
Issuance of common stock in connection with warrant exercise |
|
| — |
|
|
| — |
|
|
| 387 |
|
|
| 1 |
|
|
| (1 | ) |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
Issuance of warrants |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 332 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 332 |
|
Balances, September 30, 2020 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 17,966 |
|
| $ | 19 |
|
| $ | 451,271 |
|
| $ | (9,647 | ) |
| $ | (409,911 | ) |
| $ | 2,129 |
|
| $ | 33,866 |
|
5
|
| Three Months Ended September 30, 2019 |
| |||||||||||||||||||||||||||||||||||||
|
| Series B Convertible Preferred Stock |
|
| Common Stock |
|
| Additional Paid-in |
|
| Treasury |
|
| Accumulated |
|
| Accumulated Other Comprehensive |
|
| Noncontrolling |
|
| Total Stockholders' |
| ||||||||||||||||
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Capital |
|
| Stock |
|
| Deficit |
|
| Income |
|
| Interest |
|
| Equity |
| ||||||||||
Balances, June 30, 2019 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 16,786 |
|
| $ | 18 |
|
| $ | 446,819 |
|
| $ | (8,656 | ) |
| $ | (404,752 | ) |
| $ | 2,276 |
|
| $ | (170 | ) |
| $ | 35,540 |
|
Net income |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 1,069 |
|
|
| — |
|
|
| — |
|
|
| 1,069 |
|
Unrealized loss from foreign currency translation adjustments |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| (369 | ) |
|
| — |
|
|
| (369 | ) |
Issuance of common stock in connection with vesting of stock awards |
|
| — |
|
|
| — |
|
|
| 136 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
Stock-based compensation |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 689 |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 689 |
|
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units |
|
| — |
|
|
| — |
|
|
| (39 | ) |
|
| — |
|
|
| — |
|
|
| (185 | ) |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (185 | ) |
Liquidation of subsidiary with noncontrolling interest |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| (137 | ) |
|
| — |
|
|
| — |
|
|
| (33 | ) |
|
| 170 |
|
|
| — |
|
Balances, September 30, 2019 |
|
| 5,000 |
|
| $ | 5 |
|
|
| 16,883 |
|
| $ | 18 |
|
| $ | 447,371 |
|
| $ | (8,841 | ) |
| $ | (403,683 | ) |
| $ | 1,874 |
|
| $ | — |
|
| $ | 36,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|